Interferon β therapy increases serum ferritin levels in patients with relapsing-remitting multiple sclerosis
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Serum ferritin levels have been found to be increased in patients with active progressive multiple sclerosis (MS). However, its levels are reported to be unchanged in stable and in active relapsing-remitting (RR) form of the disease. No research to date has assessed the influence of interferon beta (IFN-beta) on ferritin concentrations. In this study, serum ferritin levels were measured in 43 individuals with RR-MS and 38 age- and sex-matched control volunteers. There were no significant differences between controls and patients under stable and untreated conditions. In patients at 12 months after the beginning of IFN-beta therapy, ferritin levels were higher in women and in men, in comparison with baseline (71.4 +/- 58.6 vs 43.4 +/- 29.9 ng/mL, P = 0.0006 and 216.0 +/- 124.3 vs 127.8 +/- 74.9 ng/mL, P = 0.0022, respectively). These results suggest that larger prospective studies are required to evaluate the role of serum ferritin in MS and its potential usefulness in monitoring responses to immunomodulatory therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Serum ferritin is a marker of inflammation that is routinely measured in patients receiving CAR T-cell therapy and may be elicited by interleukin-6 (IL-6) or type I or II IFNs.”
From Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma (2021) · cites this paper as [31]
Citations
Cites
Regulation of ferritin genes and protein
Torti, F. M., & Torti, S. V. (2002) · Blood · doi:10.1182/blood.v99.10.3505 · Cited by 1,173 · cited 2×
“Ferritin expression is up-regulated by iron, oxidants, hypoxia, and some cytokines, among other factors, and is thought to play an important role against inflammatory and oxidative injury [8].”
BackgroundHeme oxygenase-1: unleashing the protective properties of heme
Otterbein, L. E., Soares, M. P., Yamashita, K., & Bach, F. H. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00181-9 · Cited by 1,166
Novotný, L., & Vítek, L. (2003) · Experimental Biology and Medicine · doi:10.1177/15353702-0322805-29 · Cited by 347
Williams, M. J. A., Poulton, R., & Williams, S. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00233-2 · Cited by 171
Mehindate, K., Sahlas, D. J., Frankel, D., Mawal, Y., Liberman, A., Corcos, J., Dion, S., & Schipper, H. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00354.x · Cited by 129 · cited 1×
“Interferon-β has indeed been shown to counteract the stimulatory effects of proinflammatory cytokines on HO-1 expression [9].”
BackgroundWolff, B., Völzke, H., Lüdemann, J., Robinson, D., Vogelgesang, D., Staudt, A., Kessler, C., Dahm, J. B., John, U., & Felix, S. B. (2004) · Stroke · doi:10.1161/01.str.0000114875.31599.1c · Cited by 108 · cited 1×
“Mean ferritin levels in untreated patients were higher in men than in women and were similar to those found by other authors in normal populations [6,7].”
ResultLeVine, S. M., LYNCH, S. G., Ou, C., Wulser, M. J., Tam, E., & Boo, N. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01360-2 · Cited by 99
Elevated urinary excretion of aluminium and iron in multiple sclerosis
Exley, C., Mamutse, G., Korchazhkina, O., Pye, E., Strekopytov, S., Polwart, A., & Hawkins, C. (2006) · Multiple Sclerosis Journal · doi:10.1177/1352458506071323 · Cited by 98
Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients
Sfagos, C., Makis, A. C., Chaidos, A., Hatzimichael, E. C., Dalamaga, A., Kosma, K., & Bourantas, K. L. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1171oa · Cited by 84
HOFER, H. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.02.030 · Cited by 64
Cited by
Jain, M. D., Zhao, H., Wang, X., Atkins, R., Menges, M., Reid, K., Spitler, K., Faramand, R., Bachmeier, C., Dean, E. A., et al. (2021) · Blood · doi:10.1182/blood.2020007445 · Cited by 297
Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency
Worthington, V., Killestein, J., Eikelenboom, M. J., Teunissen, C. E., Barkhof, F., Polman, C. H., Uitdehaag, B. M. J., & Petzold, A. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fb449e · Cited by 56
In vivo imaging of spinal cord atrophy in neuroinflammatory diseases
Liu, W., Nair, G., Vuolo, L., Bakshi, A., Massoud, R., Reich, D. S., & Jacobson, S. (2014) · Annals of Neurology · doi:10.1002/ana.24213 · Cited by 47
Stojković, L., Djordjević, A., Stefanović, M., Stanković, A., Dinčić, E., Djurić, T., & Živković, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011024 · Cited by 28
Knyszyńska, A., Radecka, A., Zabielska, P., Łuczak, J., Karakiewicz, B., & Lubkowska, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186818 · Cited by 26
Metadata
- Authors
- Sena, A., Pedrosa, R., Ferret-Sena, V, Cascais, M., Roque, R., Araújo, C., & Couderc, R.
- Affiliations
- Hospital Santo António dos Capuchos (PT)
- Departmento de Fisiologia, Cooperative Egas Moniz, Monte da Caparica, Portugal
- Departamento de Bioquimica, Faculdade de Ciencias Médicas, Lisbon, Portugal
- Hôpital Armand-Trousseau (FR)
- Corresponding author
- Sena, A
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2008-07
- Volume
- 14
- Issue
- 6
- Pages
- 857-859
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W2118921893
- Cited by
- 12
- References
- 14
- Citations by year
- 2024: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Multiple Sclerosis Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Biogen
- IC Design Education Center
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- interferon-beta, serum ferritin, relapsing-remitting multiple sclerosis, immunomodulatory therapy, sex differences, treatment response monitoring, iron metabolism
- MeSH terms
- Interferon beta-1a, Interferon beta-1b, Adjuvants, Immunologic, Adult, Bilirubin, Female, Ferritins, Hemoglobins, Humans, Male, Middle Aged, Sex Characteristics, Interferon-beta, Drug Monitoring, Multiple Sclerosis, Relapsing-Remitting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interferon β therapy increases serum ferritin levels in patients with relapsing-remitting multiple sclerosis. https://app.cochat.ai/papers/10.1177/1352458508089687
- The paper
- Sena, A., Pedrosa, R., Ferret-Sena, V, Cascais, M., Roque, R., Araújo, C., & Couderc, R. (2008). Interferon β therapy increases serum ferritin levels in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. https://doi.org/10.1177/1352458508089687
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.